NEW YORK (Reuters Health) - For men with aggressive Prostate Cancer, hormone-targeted therapy cuts the overall risk of death, according to a new review of past studies. It also does not increase the chance that men will die from Cardiovascular Disease -- which some research had suggested might be the case, researchers reported in the Journal of the American Medical Association on Tuesday. "I think that these results should be very reassuring for the majority of patients who are thinking of Androgen Deprivation Therapy for their prostate cancer," said Dr. ...read more..
source:http://yhoo.it/sl1PSB
No comments:
Post a Comment